Manager
WELZIA MANAGEMENT, SGIIC, S.A.
See the CNMV manager universe →
Fund page
A&P LIFESCIENCE FUND, FI
Category
—
Latest period
H2 2025
Positions
48
Portfolio as of 2025-12-31. Source: periodic filing with the CNMV. View original filing (PDF)
Full portfolio
Every position in the latest periodic filing, largest weight first. Aggregates ("other equities...") are baskets of small positions the filing itself does not break out line by line.
48
Company
Type
Country
Weight
Price
This period's moves
H2 2025 vs H1 2025 (estimated)
New: 8
Exits: 10
Increases: 18
Cuts: 8
− ACCIONES|Verona Pharma PLC
Leaves the portfolio; it was 5.35% of weight.
− ACCIONES|SpringWorks Therapeu
Leaves the portfolio; it was 2.61% of weight.
− ACCIONES|Agios Pharmaceutical
Leaves the portfolio; it was 2.13% of weight.
− ACCIONES|Cytokinetics Inc
Leaves the portfolio; it was 0.98% of weight.
− ACCIONES|Metsera Inc
Leaves the portfolio; it was 0.94% of weight.
− ACCIONES|89bio Inc
Leaves the portfolio; it was 0.92% of weight.
− ACCIONES|Blueprint Medicines
Leaves the portfolio; it was 0.91% of weight.
− ACCIONES|Novo-Nordisk
Leaves the portfolio; it was 0.86% of weight.
− ACCIONES|Becton Dickinson
Leaves the portfolio; it was 0.62% of weight.
− ACCIONES|Amicus Therapeutics
Leaves the portfolio; it was 0.53% of weight.
Disclaimer
This is not financial advice. The portfolio comes from the periodic report the fund files with the CNMV and lags the real close of the period: it is a snapshot of the end of each half-year, not a real-time portfolio.